BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Consultancies, law firms and service providers at BIO‑Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

40 consultancies, law firms and service providers are at BIO-Europe 2026 — 48 presentations on the program. Most represented: Informa (4 on the program), Graythan Regulatory Services (2 on the program), Ropes & Gray (2 on the program). 33 of them have their own page in this guide. As of Nov 10, 2026.

All 473 organizations at BIO-Europe 2026 →

Track
Top represented
Showing 1–14 of 40 organizations
OrganizationBIO-Europe 2026 Attendance
Informa
London, United Kingdom
Consulting, legal & services
Events, publishing and data group that runs BIO-Europe and publishes BioXconomy.
Keynote
Mon Nov 9
10:15–10:30
Opening Remarks
The Big Picture Plenary Series · with Ministry of Economic Affairs, Industry, Climate Action and Energy of North Rhine-Westphalia, Biotechnology Innovation Organization (BIO)
Talk
Mon Nov 9
09:30–10:00
partneringONE essentials workshop
Newcomers learn what to expect from partnering meetings, including timing and etiquette, and how to get the most from the partneringONE system.
Panel
Tue Nov 10
09:00–09:45
Networks or neurons: What’s next in CNS dealmaking?
What is driving recent deals between biotechs and larger drug companies for brain and nervous system drugs, which remain hard to develop.
with Servier, Biovance Capital, Otsuka +2 more
Talk
Tue Nov 10
11:30–12:00
partneringONE power up workshop
Experienced delegates learn advanced partneringONE features and team habits that save time and raise how often their meeting requests are accepted.
Panel
Wed Nov 11
13:00–13:45
BIO-Europe Media Round-Up: The Stories Shaping Biopharma Right Now
Journalists pick out the biggest biopharma news stories and deal trends of the moment and explain what they mean for dealmakers.
with BioWorld
Panel
Wed Nov 11
09:00–09:45
How is the APAC region reshaping global biopharma?
How China, Japan, South Korea and other Asia-Pacific countries are moving from making drugs to inventing them, and how Western firms can partner.
with MSD, Sinovoy Health Group, WinHealth Pharma +1 more
Consulting, legal & services
Regulatory consultancy advising drug developers on regulatory and commercialization pathways, including gene therapy applications.
Panel
Mon Nov 9
14:00–14:45
Community Conversations – Session 1
Attendees join small-group lunch tables on a topic of their choice, from regulatory strategy and global launches to hiring talent and managing partnerships.
with R Kupiec Consulting, Sartorius, Venture Valuation +3 more
Business of BiotechRegulatory Strategy
Panel
Mon Nov 9
15:00–15:45
Community Conversations – Session 2
A second round of the same small-group lunch tables, letting attendees switch to another topic such as regulatory strategy, launches or partnerships.
with R Kupiec Consulting, Sartorius, Venture Valuation +3 more
Business of BiotechRegulatory Strategy
Panel
Tue Nov 10
13:00–13:55
Unlocking APACs Clinical Trials Potential: Navigating Regulatory Pathways, Bridging Strategies and Market Access Across the Region
How to run clinical trials and win approval in Japan, Korea, Taiwan and Southeast Asia, and when studies in local patients pay off.
with HiRO, CMIC Group, Differentia Bio
Ropes & Gray
Boston, MA
◆Gold Sponsor
Consulting, legal & servicesGold sponsor
International law firm advising life sciences companies and investors on transactions, financing and intellectual property.
Panel
Tue Nov 10
16:00–16:45
Capital, Creativity, and Optionality: The New Anatomy of Life Sciences Transactions
How biotechs raise money by selling rights to future drug sales, spinning off new companies, or going public by merging with a listed one.
with Astellas, HealthCare Royalty, Regeneron
Panel
Tue Nov 10
10:45–11:15
From Partnering Pioneer to Global Biotech Leader: The Next Chapter for European Innovation
How Genmab grew from licensing its discoveries to others into a global company selling its own drugs, and what European biotechs can learn.
with Genmab
59 North Communications
Stockholm, Sweden
Consulting, legal & services
Communications agency providing branding, PR and digital marketing for life science, biotech and pharmaceutical companies.
Panel
Mon Nov 9
16:15–17:00
Building the Next Global Biotech Hubs: What Makes an Innovation Ecosystem Work?
What makes a region a strong biotech hub, from talent, labs and funding to links with global drug companies.
with Gateway Factory, CSL Behring, Sound Bioventures +1 more
Panel
Wed Nov 11
11:00–11:45
AI-Powered Ecosystems: Transforming Drug Discovery Through Digital Collaboration
How drug, biotech and tech companies can build AI partnerships, and why AI finds easier wins in early discovery than in later clinical stages.
with OKG Capital, Earlybird Venture Capital, endogene.bio +1 more
Strategic Transactions Advisory
Binningen, Switzerland
Consulting, legal & services
Boutique advisory supporting biotech and pharma companies on business development, licensing, M&A and alliance management.
Panel
Mon Nov 9
14:00–14:45
Community Conversations – Session 1
Attendees join small-group lunch tables on a topic of their choice, from regulatory strategy and global launches to hiring talent and managing partnerships.
with R Kupiec Consulting, Graythan Regulatory Services, Sartorius +3 more
Business of BiotechRegulatory Strategy
Panel
Mon Nov 9
15:00–15:45
Community Conversations – Session 2
A second round of the same small-group lunch tables, letting attendees switch to another topic such as regulatory strategy, launches or partnerships.
with R Kupiec Consulting, Graythan Regulatory Services, Sartorius +3 more
Business of BiotechRegulatory Strategy
Consulting, legal & services
Australian not-for-profit organization providing human research ethics committee review for clinical trials and other health research.
Panel
Wed Nov 11
09:55–10:25
What Starts Down Under Doesn’t Stay Down Under: Australian Clinical Data as a Global Launchpad
How companies use clinical data gathered in Australia to move into multinational trials, raise investment and launch products worldwide.
with Alithia Life Sciences, Crux Biolabs, CMAX Clinical Research +1 more
Panel
Mon Nov 9
14:00–14:45
Community Conversations – Session 1
Attendees join small-group lunch tables on a topic of their choice, from regulatory strategy and global launches to hiring talent and managing partnerships.
with Graythan Regulatory Services, Sartorius, Venture Valuation +3 more
Business of BiotechRegulatory Strategy
Panel
Mon Nov 9
15:00–15:45
Community Conversations – Session 2
A second round of the same small-group lunch tables, letting attendees switch to another topic such as regulatory strategy, launches or partnerships.
with Graythan Regulatory Services, Sartorius, Venture Valuation +3 more
Business of BiotechRegulatory Strategy
Panel
Tue Nov 10
16:00–16:45
Unlocking Clinical Trial Systems
How EU clinical trial rules and a planned EU biotech law affect trial approval times, and whether Europe can speed up safely.
with Parexel, Merck KGaA, AstraZeneca
◆Platinum Sponsor
Consulting, legal & servicesPlatinum sponsor
Cross-border life sciences platform helping biotech and medtech companies with market access, partnerships, investment and transactions between China and global markets.
Talk
Tue Nov 10
09:30–09:45
Midsize Pharma: Sinovoy Health Group
A cross-border life sciences company that helps Chinese and global drug makers move new therapies between markets, from regulatory planning to deals.
Panel
Wed Nov 11
09:00–09:45
How is the APAC region reshaping global biopharma?
How China, Japan, South Korea and other Asia-Pacific countries are moving from making drugs to inventing them, and how Western firms can partner.
with Informa, MSD, WinHealth Pharma +1 more
Consulting, legal & services
News site and job board covering the biotech, pharmaceutical and clinical research industries.
Panel
Tue Nov 10
15:00–15:25
Scaling Biologics Manufacturing in a Changing World: How Biopharma is Rethinking Launches, Partnerships and Resilience
How political uncertainty and trade shifts are changing how drug companies pick outside manufacturers, including whether to produce closer to home.
with Lonza
Chair
Wed Nov 11
08:55–09:00
Chairperson Opening Remarks
Biomanufacturing Strategy
Consulting, legal & services
Consultancy advising pharma, medtech and digital health companies on China-Europe policy, regulation, market access and expansion.
Talk
Tue Nov 10
09:30–09:45
Before the Deal: What Western Buyers Must Resolve About China-Origin Evidence and Policy Risk
What Western buyers should check before buying rights to a China-developed drug, from whether its trial data satisfy European regulators to political risk.
Panel
Tue Nov 10
09:45–10:45
China’s Clinical Revolution: From Regional Player to Global Innovation Engine
Why global drug companies license more drugs from Chinese biotechs, and how China's fast trials and changing rules can speed worldwide development.
with Tigermed, MSQ Ventures, Alkeus Pharmaceuticals
Venture Valuation
Zurich, Switzerland
Consulting, legal & services
Values life science companies and assets and runs the Biotechgate business development database.
Panel
Mon Nov 9
14:00–14:45
Community Conversations – Session 1
Attendees join small-group lunch tables on a topic of their choice, from regulatory strategy and global launches to hiring talent and managing partnerships.
with R Kupiec Consulting, Graythan Regulatory Services, Sartorius +3 more
Business of BiotechRegulatory Strategy
Panel
Mon Nov 9
15:00–15:45
Community Conversations – Session 2
A second round of the same small-group lunch tables, letting attendees switch to another topic such as regulatory strategy, launches or partnerships.
with R Kupiec Consulting, Graythan Regulatory Services, Sartorius +3 more
Business of BiotechRegulatory Strategy
◇Silver Sponsor
Consulting, legal & servicesSilver sponsor
Life sciences consultancy advising biopharma companies on commercial strategy, market access and product launches.
Talk
Mon Nov 9
09:00–10:00
Build, Buy, or Partner? Choosing Your Market Entry Strategy
How drug companies choose between licensing a new product to a regional partner, selling it themselves, or both, with lessons from each path.
with Idorsia, Protagonist Therapeutics, Biogen
Business of Biotech
Consulting, legal & services
Clarivate's daily news service on biopharma and medical technology deals, financings, clinical results and regulation.
Panel
Wed Nov 11
13:00–13:45
BIO-Europe Media Round-Up: The Stories Shaping Biopharma Right Now
Journalists pick out the biggest biopharma news stories and deal trends of the moment and explain what they mean for dealmakers.
with Informa
Consulting, legal & services
News outlet covering biopharma partnering, investment and business development.
Panel
Wed Nov 11
11:00–11:45
Funding Outside the Box: Alternative Financing Strategies for Startups
Ways biotech startups can raise money besides venture investors, such as loans or selling a share of future sales, and when each fits.
with HealthCare Royalty, Claret Capital Partners, OrbiMed

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from consultancies, law firms and service providers

Tell us what you sell and we’ll find the people at these consultancies, law firms and service providers most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse BIO-Europe 2026 by

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction